Epizyme Inc. Closes Follow-On Offering

Download IconDownload Print IconPrint

Epizyme Inc. Closes Follow-On Offering

Firm News

Related Solutions

Leveraging our sophisticated technical, market and legal experience to help clients effectively and efficiently manage complex transactions and get the deal done.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.

WilmerHale represented Epizyme Inc. in its follow-on offering announced on January 12, 2016.

The WilmerHale team was led by Partner Stuart Falber and included Partner Bruce Manheim, Counsel Carolyn Rucci and Associate Julie Fogarty.

Further details can be found in Epizyme's press release announcing the closing of the transaction.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel